Filter
1793
Filtered Results: 1793
Text search:
pharmaceutical
products
Featured
Recommendations
164
New Publications
508
Language
Document type
No document type
917
Studies & Reports
337
Guidelines
271
Manuals
93
Strategic & Response Plan
78
Fact sheets
41
Training Material
27
Situation Updates
13
Resource Platforms
9
Infographics
4
Online Courses
2
Brochures
1
Countries / Regions
Kenya
71
Global
66
Ethiopia
64
India
57
Nigeria
40
Western and Central Europe
38
South Africa
37
Sierra Leone
34
Uganda
33
Liberia
33
Ghana
29
Rwanda
29
Nepal
26
Tanzania
26
Namibia
26
Malawi
24
Zambia
24
Ukraine
21
Philippines
19
Bangladesh
19
Africa
18
Zimbabwe
15
Cambodia
14
Latin America and the Carribbean
14
Eastern Europe
14
Indonesia
14
Myanmar / Burma
14
Lesotho
13
South–East Asia Region
13
Eswatini/ Swaziland
12
Syria
10
West and Central Africa
10
Botswana
10
Eastern Europe and Central Asia
9
Congo, Democratic Republic of
8
East and Southern Africa
8
Burkina Faso
6
Guinea
6
Asia
6
Senegal
5
Haiti
5
Venezuela
5
Germany
5
South Sudan
5
Thailand
4
Benin
4
Cameroon
4
Albania
4
Middle East and North Africa
4
Russia
4
Pakistan
4
North Macedonia
3
China
3
Fiji
3
Laos
3
Mozambique
3
USA
3
Jordan
3
Western Pacific Region
3
North America
3
Vietnam
3
Sudan
3
Mali
3
Tajikistan
2
Serbia
2
Kyrgyzstan
2
Afghanistan
2
Peru
2
Jamaica
2
United Kingdom
2
Southern Africa
2
Lebanon
2
Papua New Guinea
2
Brazil
2
Moldova
2
Egypt
2
Georgia
2
Central African Republic
2
Madagascar
2
Timor Leste/ East Timor
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Malaysia
1
Mongolia
1
Bulgaria
1
Armenia
1
Ireland
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Sri Lanka
1
Yemen
1
Angola
1
Libya
1
Bhutan
1
Iraq
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
715
Clinical Guidelines
128
Public Health
97
Key Resources
69
Women & Child Health
51
Pharmacy & Technologies
38
Capacity Building
13
Annual Report MEDBOX
1
Toolboxes
Pharmacy
195
AMR
179
COVID-19
127
TB
85
Mental Health
83
HIV
82
Rapid Response
56
Planetary Health
54
NTDs
39
Global Health Education
38
NCDs
36
Caregiver
35
Ebola
33
Conflict
29
Health Financing Toolbox
27
Specific Hazards
13
Refugee
12
Disability
10
Natural Hazards
9
Polio
9
Cholera
3
Social Ethics
3
Zika
3
Health Financing
1
Responding to community spread of COVID-19
recommended
Interim Guidance 7 March 2020
This document provides technical guidance for government authorities, health workers, and other key stakeholders to guide response to community spread. It will be updated as new information or technical guidance become available. For countries that are already preparin...
This action plan for the Kingdom Saudi Arabia to combat antimicrobial resistance has been formulated in the line of the WHO five objectives. It addresses the need for effective “one health” approach involving coordination among numerous national sectors and actors, including human and veterinary...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl...
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po...
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited...
The most significant finding of the case study for integrating antimicrobial resistance (AMR)into existing programs and mobilising resources for funding in Nigeria, is that most of the AMR activities within the Nigerian National Action Plan (NAP)canalready be incorporated within exi...
This working paper was conceived to offer practical tips and suggestions on how to establish and sustain the multisectoral coordination needed to develop and implement National Action Plans on AMR (NAPs). It is intended for anyone with responsibility for addressing AMR at country level. Drawing on b...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List ...
The National Department of Health and Department of Agriculture, Forestry and Fisheries have collectively engaged to determine the key interventions that will form the basis for this strategy taking into account the recommendations from the WHO and OIE.
The development and implementation of a Natio...
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptio...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
